Abstract: The invention provides therapeutic methods that include administering a stable nitroxide to a subject that has, is suspected to have, or is at risk for having a condition associated with reduced VHL or elevated HIF-2?.
Type:
Application
Filed:
November 30, 2010
Publication date:
November 22, 2012
Applicant:
USDHHS Office of Technology, NIH
Inventors:
W. Marston Linehan, Tracey A. Rouault, James Mitchell, Murali K. Cherukuri